See all posts tagged: "LUNG CANCER DRUG THERAPY"

img
Chemotherapy-free regimen (with NK and T cell activation via Anktiva) in patients with multiple tumor types who failed checkpoint inhibitor treatment 140 patients collected to date in this basket trial of checkpoint failures in lung cancer, melanoma, urothelial, head and neck, stomach and cervical cancers...
img
Socazolimab is an anti-PD-L1 antibody licensed for the Greater China Territory by Lee's Pharm in Sorrento.China's National Medical Products Administration ("NMPA") authorizes Lee's Pharm to conduct a Phase III, multicenter, randomized, double-blind, parallel-group clinical trial of Socazolimab (anti-PD-L1 monoclonal antibody, formerly known as ZKAB001) in...
1 2 55

Above are the posts tagged "LUNG CANCER DRUG THERAPY"

View Publication by Topic

(***)

(***)

Tags: ADVANCED LUNG CANCER TREATMENT STAGE 2, ADVANCED LUNG CANCER TREATMENT STAGE 3, ANY NEW TREATMENTS FOR SMALL CELL LUNG CANCER, ARE CANCER CLINICAL TRIALS SAFE

Thank You For Reading our "LUNG CANCER DRUG THERAPY" Tag Page. Please bookmark this page and check back often to keep up-to-date with our latest news.

This div height required for enabling the sticky sidebar